Professional Basketball Player
2016 World Champion
Severe Asthma sufferer
Richard Jefferson is a BT patient and a paid spokesperson of the Alair™ System
Patients who chose BT to better manage their severe asthma
“It was the day-to-day things that I really started noticing were easier to do.” — Theresa - US Patient
“I’ve been able to cut the grass. I’ve been able to work on my car. I wasn’t able to travel. I’ve been able to travel, something I haven’t done for years.” — Angel - US Patient
“BT has changed my quality of life altogether. After BT, I can put more air through my horn.” — Chris - US Patient
“For me, BT gave me a breath of life, I can breathe almost as a normal person, an experience I almost forgotten.” — You Guang - Singapore Patient
“Now I can live life and go and do those fun activities that I hadn’t done before. If you really want to live life and you really don’t want a disease that’s controlling your life or defining you, have BT.” — LaRetta - US Patient
“It was a moment of revelation. It’s that sun breaking through the clouds and you go, ‘It worked.’” — Chris - US Patient
How much does asthma impact your life?
Take the Free Asthma Assessment Survey
Speak with a trained health care professional who can assist you in connecting with a BT-certified pulmonologist for an appointment.
Monday-Friday 9:00 AM — 8:00 PM Eastern
Join theIt’s About BreathingCommunity
Learn how BT has helped people with severe asthma gain control of their asthma symptoms and improve their asthma-related quality of life.
The Alair™ Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists.
As with any procedure, there are risks, and individual results may vary. The most common adverse event of BT is a temporary worsening of respiratory-related symptoms. These events typically occur within one day of the BT procedure and usually resolve within a week with standard care. There is a small risk (3.4% per procedure) that symptoms may require hospitalization.2